Sugi Predict

Sugi Predict / Compounds / SCHEMBL610893

SCHEMBL610893

SCHEMBL610893

Brc1cccc(C2CO2)c1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.54
▸ KDM1A O60341 5/20 0.52
▸ PARP1 P09874 1/20 0.50
▸ HTR2A P28223 1/20 0.49
▸ HTR2C P28335 1/20 0.49
▸ HTR2B P41595 1/20 0.49
▸ RCOR1 Q9UKL0 2/20 0.41
▸ FFAR1 O14842 3/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ DRD2 P14416 2/20 0.39
▸ DRD3 P35462 2/20 0.39
▸ HDAC4 P56524 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ DRD1 P21728 1/20 0.37
▸ DRD4 P21917 1/20 0.37
▸ DRD5 P21918 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29364885 1.00 TSHR (0.54) TSHRKDM1APARP1HTR2AHTR2C
SCHEMBL7784351 1.00 TSHR (0.54) TSHRKDM1APARP1HTR2AHTR2C
SCHEMBL610892 1.00 TSHR (0.54) TSHRKDM1APARP1HTR2AHTR2C
SCHEMBL21974861 0.84 TSHR (0.67) TSHRPARP1MEN1KMT2ADRD2
SCHEMBL46283 0.84 TSHR (0.67) TSHRPARP1MEN1KMT2ADRD2
SCHEMBL27997313 0.79 KDM1A (0.44) KDM1AHTR2AHTR2CHTR2BRCOR1
SCHEMBL13551110 0.77 KDM1A (0.43) KDM1AHTR2AHTR2CHTR2BRCOR1
Water SCHEMBL10412066 0.77 KDM1A (0.43) KDM1AHTR2AHTR2CHTR2BRCOR1
SCHEMBL27988042 0.77 KDM1A (0.43) KDM1APARP1HTR2AHTR2CHTR2B
SCHEMBL1810741 0.77 KDM1A (0.50) KDM1AHTR2AHTR2CHTR2BRCOR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115927276-B Halohydrin dehalogenase mutant and application thereof in synthesis of chiral oxazolidinone 中国科学院天津工业生物技术研究所 2024-08-27 — — CN claimed
CN-111217769-B Method for synthesizing epoxy compound by catalyzing olefin epoxy by using nano alumina 华南理工大学 2023-04-21 — — CN claimed
CN-115927276-A Halogen alcohol dehalogenase mutant and application thereof in synthesizing chiral oxazolidinone 中国科学院天津工业生物技术研究所 2023-04-07 — — CN claimed
CN-113980467-A Conductive composite PPS material and preparation method thereof 上海普利特伴泰材料科技有限公司 2022-01-28 — — CN claimed
US-20260042758-A1 AZAINDOLE DERIVATIVES AND THEIR USE AS ERK KINASE INHIBITORS AGV DISCOVERY (FR) 2026-02-12 — — US disclosed
CN-119662579-A Styrene monooxygenase mutant and application thereof 中国科学院成都生物研究所 2025-03-21 — — CN disclosed
EP-4463453-A1 AZAINDOLE DERIVATIVES AND THEIR USE AS ERK KINASE INHIBITORS AGV Discovery (FR) 2024-11-20 — — EP disclosed
US-20240308997-A1 AZAINDOLE DERIVATIVES AND THEIR USE AS ERK KINASE INHIBITORS AGV DISCOVERY (FR) 2024-09-19 — — US disclosed
CN-115927276-B Halohydrin dehalogenase mutant and application thereof in synthesis of chiral oxazolidinone 中国科学院天津工业生物技术研究所 2024-08-27 — — CN disclosed
US-11827637-B2 Azaindole derivatives and their use as ERK kinase inhibitors AGV DISCOVERY (FR) 2023-11-28 — — US disclosed
US-11827637-B2 Azaindole derivatives and their use as ERK kinase inhibitors AGV DISCOVERY (FR) 2023-11-28 — — US disclosed
US-20230227451-A1 AZAINDOLE DERIVATIVES AND THEIR USE AS ERK KINASE INHIBITORS AGV DISCOVERY (FR) 2023-07-20 — — US disclosed
US-5717116-A TREATING A MIXTURE OF PHENYLHALOGENOMETHYLCARBINOLS WITH A LIPASE IN THE PRESENCE OF A CARBOXYLATE FOLLOWED BY CYCLIZATION WITH A BASE SUMIKA FINE CHEMICALS COMPANY, LIMITED (JP) 1998-02-10 — — US disclosed
US-5672504-A TREATING MIXED EPOXIDE ENANTIOMORPHS WITH MICROORGANISMS TO INCREASE CONCENTRATION OF OPTICALLY PURE S-ENANTIOMORPHS DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1997-09-30 — — US disclosed
WO-1997020847-A1 TRICYCLIC IBOGAINE ANALOGS, THEIR PREPARATION AND THEIR USE IN TREATING SUBSTANCE ABUSE REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 1997-06-12 — — WO disclosed
US-5616575-A COCAINE ADDICTION REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 1997-04-01 — — US disclosed
EP-0735142-A2 Process for producing (R)-styrene oxides SUMIKA FINE CHEMICAL COMPANY, LTD. (JP) 1996-10-02 — — EP disclosed
EP-0611826-A2 Processes for production of optically active epoxides DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1994-08-24 — — EP disclosed
US-5017619-A Anitdiabetic HOFFMANN-LA ROCHE INC. (US) 1991-05-21 — — US disclosed
EP-0244088-A2 1-Phenyl-3-benzazepine compounds and medicaments containing these compounds for treating gastrointestinal motility disorders SMITHKLINE BEECHAM CORPORATION (US) 1987-11-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11827637-B2 Azaindole derivatives and their use as ERK kinase inhibitors MAPKAPK2, MAPK1, MAPK7 TSHR 2181/4885KDM1A 1605/4885PARP1 1494/4885
US-20260042758-A1 AZAINDOLE DERIVATIVES AND THEIR USE AS ERK KINASE INHIBITORS BRAF, RAF1, NRAS TSHR 929/4885KDM1A 2926/4885PARP1 1999/4885
US-20230227451-A1 AZAINDOLE DERIVATIVES AND THEIR USE AS ERK KINASE INHIBITORS MAPKAPK2, MAPK1, MAPK7 TSHR 2181/4885KDM1A 1605/4885PARP1 1494/4885
US-20240308997-A1 AZAINDOLE DERIVATIVES AND THEIR USE AS ERK KINASE INHIBITORS MAPKAPK2, MAPK1, MAPK7 TSHR 2181/4885KDM1A 1605/4885PARP1 1494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.